| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 152529-70-9 | Cyclopentanecarboxamide,N-(4-amino-1,2,3,6-tetrahydro-2,6-dioxo-1-propyl-5-pyrimidinyl)-; Cyclopentanecarboxamide, N-(4-amino-1,2,3,6-tetrahydro-2,6-dioxo-1-propyl-5-pyrimidinyl)- |  | C13H20N4O3 | 詳情 | 供應商 | |
| 142181-97-3 | Hydrazinecarboxylicacid, 1-(3-aminopropyl)-2-[(dimethylamino)carbonyl]-, phenyl ester; N(alpha)-(N,N-dimethylcarbamoyl)-alpha-azaornithine phenyl ester |  | C13H20N4O3 | 詳情 | 供應商 | |
| 31652-52-5 | Urea,N-cyclohexyl-N'-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)-; Urea,1-cyclohexyl-3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)- (8CI) |  | C13H20N4O3 | 詳情 | 供應商 | |
| 100324-81-0 | 1H-Purine-2,6-dione,3,7-dihydro-1-[(5R)-5-hydroxyhexyl]-3,7-dimethyl-; 1H-Purine-2,6-dione,3,7-dihydro-1-(5-hydroxyhexyl)-3,7-dimethyl-, (R)-; CT 1501R; Lisofylline; Lisophylline; ProTec |  | C13H20N4O3 | 詳情 | 供應商 | |
| 107767-55-5 | 1H-Purine-2,6-dione,3,9-dihydro-1-(5-hydroxy-5-methylhexyl)-3-methyl-; 1H-Purine-2,6-dione,3,7-dihydro-1-(5-hydroxy-5-methylhexyl)-3-methyl- (9CI); 1-(5-Hydroxy-5-methylhexyl)-3-methylxanthine; A 81-3138; Albifylline; HWA 138 |  | C13H20N4O3 | 詳情 | 供應商 | |
| 2197-00-4 | 1H-Purine-2,6-dione,3,7-dihydro-1,3,7-trimethyl-8-(pentyloxy)-; Caffeine,8-(pentyloxy)- (7CI,8CI); NSC 11281 |  | C13H20N4O3 | 詳情 | 供應商 | |
| 31542-46-8 | 1H-Purine-2,6-dione,3,7-dihydro-1,3,7-trimethyl-8-(3-methylbutoxy)-; Caffeine,8-(isopentyloxy)- (8CI); NSC 11282 |  | C13H20N4O3 | 詳情 | 供應商 | |
| 37921-30-5 | 2,4(1H,3H)-Pteridinedione,5-acetyl-5,6,7,8-tetrahydro-1,3,6,7,8-pentamethyl-; 5-Acetyl-1,3,6,7,8-pentamethyl-5,6,7,8-tetrahydropteri-2,4-dione |  | C13H20N4O3 | 詳情 | 供應商 |